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ABSTRACT
 The endoplasmic reticulum is the site where integral membrane and secreted 
proteins are synthesized and folded, and is also the site of synthesis of steroids, lipids, 
and other macromolecules. While ER is found in most cell types, hepatocytes in 
particular contain large amounts of both rough and smooth ER to facilitate their tasks, 
which include lipoprotein assembly and secretion, cholesterol biosynthesis, and lipid 
metabolism. As such, stress in the ER – and the cells’ ability to respond to it – plays a 
key role in disease pathogenesis. In particular, hepatic steatosis, or fatty liver, is linked to 
ER stress.  However, if and how inherent variations in the resulting unfolded protein 
response (UPR) affect the predisposition to ER stress-associated metabolic conditions, 
including hepatic steatosis, remains to be established. By using genetically diverse deer 
mice (Peromyscus maniculatus) as a model, we show that the profile of tunicamycin-
induced UPR in fibroblasts isolated at puberty varies between individuals and predicts 
deregulation of lipid metabolism and diet induced hepatic steatosis later in life. Among 
the different UPR targets tested, CHOP more consistently predicted elevated plasma 
cholesterol and hepatic steatosis. Compared to baseline levels or inducibility, the 
maximal intensity of the UPR following stimulation best predicts the onset of pathology. 
Differences in the expression profile of the UPR recorded in cells from different 
populations of deer mice correlate with the varying response to ER stress in altitude 
adaptation. Upon analysis of gene expression in the livers, no differences in the 
expression levels of various UPR-associated genes between steatotic and nonsteatotic 
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livers were recorded. Then we asked if there is a change in the relative levels of these 
genes as compared to each other. While we did not note any changes to the coordination 
of UPR genes among themselves, we did note that there was a loss of coordination 
between ER stress genes and autophagy and metabolic genes, particularly hepatic lipase 
(HL), but only in the livers of mice who had developed steatosis. Additionally, using rat 
hepatoma cells which naturally express HL, we demonstrated that induction of ER stress 
leads to the downregulation of HL alongside the upregulation of ER stress-induced genes. 
Together, this data demonstrates the ability of tunicamycin-treated fibroblasts isolated 
early in life to predict the propensity of an individual to develop hepatic steatosis; this 
approach might also be useful for other conditions associated with ER stress, both 
metabolic and otherwise. The results of the liver analysis imply that ER stress plays a role 
in the expression of HL and potentially other important metabolic genes, and that the loss 
of coordination of ER stress response with other cellular responses could be a more 
important factor in the transition to disease than the levels of individual transcripts alone. 
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CHAPTER 1: INTRODUCTION 
 
The endoplasmic reticulum is the site where integral membrane and secreted 
proteins are synthesized and folded, and is also the site of synthesis of steroids, lipids, 
and other macromolecules (Jo et al., 2013; Rashid et al., 2015). Though the ER is a single 
membrane system with a continuous intralumenal space, it consists of several distinct 
domains, including the rough ER, smooth ER, and nuclear envelope, as well as other 
areas of the system that contact other organelles within the cell (Voeltz et al., 2002). 
These areas, though connected, perform distinct functions and have distinct protein 
compositions which reflect those functions. For example, the nuclear envelope contains 
proteins which bind to nuclear structures such as nuclear lamins and chromatin (Voeltz et 
al., 2002). The rough ER, which is found in all eukaryotic cells, is distinct from other 
areas of the ER due to the presence of ribosomes. These ribosomes occur on the surface 
of the membrane and appear as small, pronounced dark spots on electron micrographs, 
which makes the rough ER visually discernible. The presence of these ribosomes also 
affects the structure; the RER is often less convoluted than the SER (Voeltz et al., 2002). 
The rough ER is also necessary for protein translocation. The protein composition of the 
smooth ER, on the other hand, varies – along with abundance and function – from cell 
type to cell type. Liver cells, neurons, muscle cells, and steroid-synthesizing cells, all 
have an abundance of SER, though the functions performed by the SER in each cell type 
varies (Voeltz et al., 2002). For example, in the liver, the SER plays an important role in 
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detoxifying hydrophobic substances. The SER includes the transitional ER, which 
is responsible for packaging proteins for transport to the Golgi apparatus. This 
transitional ER, unlike other areas of the SER, occurs in all eukaryotic cells (Voeltz et al., 
2002). 
Under normal conditions, the process of protein folding is carefully controlled and 
performed under conditions which facilitate proper folding and discourage misfolding of 
polypeptides and the formation of protein aggregates. The process of protein folding is 
mediated by other proteins called chaperones, which serve to ensure that all synthesized 
proteins are properly folded (Rashid et al., 2015). Any proteins that are irreparably 
misfolded are targeted for degradation by the proteasome. Under physiological 
conditions, there exists a balance between the levels of unfolded proteins and the levels 
of chaperones present to fold them which results in the maintenance of homeostasis. 
However, under conditions of disease or environmental stress, excessive 
polypeptide production can overwhelm the capabilities of the protein folding machinery 
of the ER, leading to the accumulation of unfolded, misfolded, and aggregated proteins 
(Lee et al., 2015; Rashid et al., 2015). If these aberrant polypeptides accumulate to toxic 
levels, it places stress on the ER, compromising normal physiological function and 
ultimately cell survival. The cell attempts to alleviate this stress via the Unfolded Protein 
Response, or UPR (Lee et al., 2015) which depending on the duration and the intensity of 
the stress may have multiple outcomes ranging from pro-survival to pro-apoptotic.  
In mammalian cells, this response occurs through three distinct, but parallel, 
signal pathways; one mediated through inositol-requiring protein 1a (IRE1a), one 
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mediated through protein kinase-like endoplasmic reticulum kinase (PERK), and another 
mediated through activating transcription factor 6 (ATF6) (Jo et al., 2015; Lee et al., 
2015; Walter and Ron, 2011), all of which are intracellular receptors located in the ER. 
Under normal conditions, each of these sensors is bound to BiP, a chaperone which 
preferentially binds to unfolded proteins, if they are present. When unfolded proteins are 
absent, BiP remains bound to the sensors, suppressing their activity. Only when aberrant 
polypeptides begin to accumulate does BiP detach from the three sensors, allowing them 
to activate and initialize the UPR.  
Perhaps the most strongly conserved and best studied of these pathways begins 
with IRE1, which is found even in yeast, which lack the other signaling arms of the UPR 
found in mammalian cells (Walter and Ron, 2011). Under ER stress conditions, IRE1 
oligomerizes, leading to conformational changes which activate its ribonuclease (RNase) 
domain (Walter and Ron, 2011). Active IRE1 cleaves the mRNA for X-box Binding 
Protein 1 (XBP1), which are then ligated into an alternately spliced form which is 
translated into the active form of XBP1, XBP1s (Walter and Ron, 2011). This 
transcription factor activates genes related to lipid biosynthesis, to enable expansion of 
the ER, and helps to regulate the production of components of the ER-associated 
degradation system (Walter and Ron, 2011). 
The transcription factor ATF6 is initially synthesized as a 90kDa ER 
transmembrane protein. Under conditions of ER stress, ATF6 is packaged into transport 
vesicles, which are delivered to the Golgi apparatus. Here, ATF6 is cleaved: first by site-
1 protease (S1P), which removes the luminal domain, and then by site-2 protease (S2P), 
which removes the transmembrane anchor, producing a free-floating, 50kDa form of 
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ATF6 (Walter and Ron, 2011). This active form of ATF6 then moves to the nucleus, 
where it activates UPR target genes, including BiP, GRP94, and protein disulfide 
isomerase (PDI) (Walter and Ron, 2011).  
The last of the three sensors is PERK; like IRE1, PERK oligomerizes under ER 
stress conditions (Walter and Ron, 2011). When oligomerized, its kinase activity is 
produced, and it autophosphorylates itself and the translation initiation factor Eukaryotic 
translation initiation factor 2 subunit 1 (eIF2a). This prevents the formation of Eukaryotic 
initiation factor 2 (eIF2), leading to cessation of the majority of translational activity and 
reduction of the protein folding load (Walter and Ron, 2011). However, those mRNAs 
which possess a short open reading frame in their 5’ untranslated regions continue to be 
translated, even with the reduction of eIF2. Among these is the mRNA for Activating 
transcription factor 4 (ATF4), which drives the expression of DNA damage-inducible 
transcript 3 (Ddit3, also known as C/EBP homologous protein, or CHOP) and protein 
phosphatase 1 regulatory subunit 15A (PPP1R15A, also known as growth arrest DNA 
damage–inducible 34, or GADD34). CHOP, in great enough abundance, will activate 
genes relating to apoptosis. This means that the PERK pathway is capable of both pro-
survival and pro-apoptotic signaling (Walter and Ron, 2011). 
During minor to moderate ER stress, the three arms of the UPR work in concert to 
promote the restoration of homeostasis within the ER. Pro-survival UPR signaling leads 
to several outcomes. One is the cessation of protein production; the translation of most 
transcripts ceases, with the exception of those for chaperones and other UPR-related 
genes. In addition, any polypeptides that are irreparably misfolded are translocated to the 
cytosol and targeted for degradation by the proteasome, a process referred to as ER-
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associated degradation (ERAD) (Meusser et al., 2005). Finally, it signals for the 
production of lipids in order to facilitate the expansion of the ER, to accommodate the 
excess proteins and the chaperones that will be needed to fold them. 
However, if ER stress persists for too long or becomes too severe, then the UPR 
becomes proapoptotic and signals for the permeabilization of the mitochondrial 
membrane, leading to the release of cytochrome c and subsequent activation of 
executioner caspases (Merksamer et al., 2010). The exact trigger for the switch from pro-
survival to pro-apoptotic signaling is still under investigation, but there is evidence that 
varying states of IRE1 oligomerization may play a role – IRE1 oligomers will 
disassemble and be dephosphorylated after a period of time, even if ER stress has not 
been mitigated, rendering IRE1 signaling inactive and potentially serving as a signal that 
the ER stress cannot be resolved (Li et al., 2010). UPR-induced apoptosis is regulated by 
the Bcl-2 family of proteins, which is divided into three groups containing both pro-
apoptotic and anti-apoptotic factors. One of these groups, the BH3-only proteins, contains 
11 different proteins, four of which are implicated in UPR-induced apoptosis: Puma, 
Noxa, Bid and Bim (the last of which CHOP has been shown to increase the transcription 
of). These proteins are transcribed and translated – or if already translated, activated – in 
response to ER stress and go on to suppress the anti-apoptotic Bcl-2 family proteins. 
Additional evidence also suggests that, depending on cellular context, mitogen-activated 
protein kinase (MAPK) c-Jun NH2-terminal kinase (JNK) signaling can also lead to the 
suppression of anti-apoptotic Bcl-2 family members, further adding to the cell death 
signal. (Merksamer et al., 2010) 
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Because the ER is a wide-reaching membrane system with connections to 
multiple organelles, stress of the ER ultimately affects the functioning of the entire cell. 
Though the UPR is initially intended to be a pro-survival mechanism, if ER stress persists 
for too long or becomes too extreme, the UPR becomes pro-apoptotic, and the stressed 
cell dies. Under ideal conditions, the pro-apoptotic response would be beneficial in the 
elimination of dysfunctional cells. Under stress conditions, however, widespread ER 
stress and cell death can lead to the development of disease. 
ER stress is linked to many diseases, some of which are or can become quite 
severe. ER stress is linked not only to cardiovascular diseases (Minamino et al., 2010), 
inflammatory conditions such as inflammatory bowel disease (Kaser et al., 2008), and 
even neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases 
(Hoozemans et al., 2012), but it plays an especially prominent role in the development of 
metabolic diseases, such as Type II diabetes and Nonalcoholic fatty liver disease 
(NAFLD). In general, ER stress is associated with the onset of pathology through the 
excessive accumulation of misfolded proteins that can form aggregates, as in the case of 
common neurodegenerative diseases. This excessive protein aggregation becomes toxic 
and can lead to cell death.  
In the pancreatic islets, the link between ER stress and pathology proceeds as 
follows: The efficient and sufficient production of the peptide hormone insulin is 
essential for the maintenance of glucose homeostasis. Insulin is synthesized and folded in 
the ER of pancreatic β-cells, which are found in clusters of cells referred to as Islets of 
Langerhans. When blood glucose levels are high, β-cells secrete insulin into the 
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bloodstream, where it performs its task of promoting the uptake of glucose by cells 
particularly by the liver, adipose tissue, and skeletal muscle.  
At conditions of sustained hyperglycemia β-cells must try to produce enough 
insulin to maintain blood glucose homeostasis, and for this reason are particularly 
susceptible to ER stress (Lee et al., 2015). Insulin resistance, in which cells lose their 
sensitivity to insulin and do not take up as much glucose from the bloodstream, leads to 
inflated blood glucose levels, which in turn stimulate additional insulin production and 
secretion. At first, healthy islets will respond to metabolic stress – brought on by obesity 
and nutritive excess – by increasing the proliferation of the β-cells to accommodate the 
increasing demand (Back et al., 2011). However, as insulin resistance worsens, it 
becomes necessary for the β-cells to produce additional insulin to counteract the 
resistance. Eventually, this reaches a point where the additional demand exceeds the 
capacity of the cell to fold the additional proteins, leading to ER stress and activation of 
the UPR. If not resolved, the UPR eventually shifts from pro-survival to pro-apoptotic, 
leading to the death of β-cells and reduction of beta cell mass. Unfortunately, this only 
compounds the problem; as β-cells begin to die off, the remaining population must try to 
compensate for the lost cells, becoming more stressed in the process and ultimately dying 
themselves. This leads to a decrease in insulin production and the development of type II 
diabetes. In type I diabetes, it is the autoimmune-mediated destruction of the β-cells 
which ultimately leads to a similar cascade of attempted compensation followed by ER 
stress and cell death. 
Because hepatic tissue is one of the tissues most responsive to insulin, insulin 
resistance also has a great effect on the liver, which is responsible for carrying out many 
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important metabolic functions. These include the assembly and secretion of lipoproteins, 
cholesterol biosynthesis, metabolism of lipids and foreign compounds, and production 
and secretion of plasma proteins (Malhi and Kaufman, 2011). These functions are all 
performed in the ER, and as such, hepatocytes contain large amounts of both rough and 
smooth ER to facilitate their tasks. Because the ER is such an important part of liver 
function, and because the liver’s functions are so critical to survival, hepatocytes must be 
able to quickly and effectively deal with ER stress. The inability of hepatocytes to 
alleviate ER stress generally leads to dysfunction and disease. ER stress of the liver can 
be caused by overnutrition, leading to the buildup of lipids in various other tissues, 
including the liver (Han and Kaufman, 2016). This leads to dyslipidemia and the 
development of hepatic steatosis, the first stage of NAFLD. Though hepatic steatosis is 
itself rather benign, it can exacerbate the problem by promoting further stress, and if left 
untreated, will progress to nonalcoholic steatohepatitis (NASH). During NASH, the liver 
becomes inflamed, and hepatocytes begin to accumulate damage in the form of continued 
ER stress, mitochondrial dysfunction, oxidative stress, and numerous other stressors and 
stress pathways. Eventually, the liver becomes fibrotic from the buildup of scar tissue; 
this damage cannot be reversed, only stopped, but if it continues, the condition advances 
to cirrhosis of the liver, liver failure, and potentially hepatocellular carcinoma. 
While the exact contribution of ER stress and the UPR to the development of 
NAFLD isn’t yet fully understood, we do know that it plays a role even in the earliest 
stage of the disease: simple hepatic steatosis. In fact, the relationship between ER stress 
and hepatic steatosis is bilateral in nature, with each promoting the development or 
progression of the other (Dara et al., 2011). During hepatic steatosis, excess triglycerides 
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– often dietary in origin – accumulate in the cytoplasm of the hepatocytes. While initially 
benign, this can easily progress to the more severe NASH if not remediated. Interestingly, 
it has been found that the mediators of ER stress – IRE1, ATF6, and PERK – are capable 
of regulating lipid stores in the liver, each through their own activities. The IRE1-XBP1 
pathway, for example, has been demonstrated to be critical for maintaining lipid 
homeostasis in stressed hepatocytes (Zhang et al., 2014). Hepatocyte-specific deletion of 
IRE1 in mice leads to the development of severe steatosis upon challenge with an ER 
stress-inducing agent; plays a role in the assembly and secretion of hepatic VLDLs; 
activating genes related to de novo lipogenesis; and upon disruption of ER homeostasis, 
is additionally important to the secretion of apolipoprotein (Zhang et al., 2014). ATF6, 
meanwhile, is important in regulating the accumulation of lipids under stress. It has been 
shown to bind to and antagonize Sterol regulatory element-binding protein 2 (SREBP2), 
thereby acting to suppress the expression of lipogenic genes and thus, the accumulation 
of lipids (Zhang et al., 2014). The PERK-eiF2α-ATF4 pathway, on the other hand, can 
contribute to the development of hepatic steatosis; compromising this pathway leads to a 
reduction in the incidence of hepatic steatosis in high-fat diet-fed animals (Zhang et al., 
2014). A study performed by Zhang et al. (2014) additionally demonstrated that ER stress 
is capable of inducing hepatic inflammation via activation of inflammasomes, protein 
complexes which promote an inflammatory response, and ultimately promotes the 
development and progression of NAFLD. Given the evidence showing the role of ER 
stress in the development of this condition, it stands to reason that individual differences 
in ER stress susceptibility and response would lead to differences in susceptibility to ER 
stress-related conditions. Because the damage to the liver from NAFLD can become 
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severe to the point of lethality, it is important to understand the complex interactions 
occurring between the UPR and other pathways, as well as characterizing the relative 
abundance of transcripts and proteins in the cell. During disease progression, the 
transcriptional profile of the cell changes, with certain genes being upregulated while 
others are suppressed. During this process, it is possible that genes belonging to the same 
transcriptional networks are co-regulated, regardless of the disease status and the 
individual genes’ abundance. Considering that disease signifies deviation from cellular 
homeostasis, it is possible that the genes that are more relevant to the disease will abolish 
this coordination, a consequence of the loss of homeostasis. These questions cannot be 
addressed by using regular inbred mice and to be answered they require genetically 
diverse models at which abundance of transcripts may be variable, yet coordination in 
gene expression likely persists. 
There are many factors which contribute to one’s likelihood of developing 
diseases such as hepatic steatosis. Increasingly, we are realizing the importance of 
genetics in the development of diseases such as NAFLD. There are a number of genetic 
mutations, affecting various pathways, which can lead to the development of NAFLD 
even in the absence of dietary triggers. Some lead to impairments in hepatic triglyceride 
export, such as the rare condition Abetalipoproteinemia, in which a mutated microsomal 
triglyceride transfer protein (MTTP) subunit leads to absence of ApoB-containing 
lipoproteins, or Familial hypobetalipoproteinemia, caused by a mutation in ApoB itself. 
In both cases, the mutations lead to an inability, or impaired ability, to export 
triglycerides from the liver, thus producing hepatic steatosis among other symptoms 
including fat-soluble vitamin deficiencies (Hooper et al., 2011). A mutation in solute 
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carrier family 25, member 13 (SLC25A13) leads to citrullinemia type II, one symptom of 
which is the enhancement of de novo lipogenesis resulting in hepatic steatosis (Hooper et 
al., 2011). Familial lipodystrophies caused by mutations in Peroxisomal proliferator-
activated receptor γ (PPARG) or the nuclear lamin A/C gene LMNA, in which the patient 
is unable to produce or maintain healthy adipose tissue, are associated with numerous 
metabolic abnormalities including hyperinsulinemia and hypertriglyceridemia, alongside 
hepatic steatosis. Other mutations can lead to impairments in hepatic fatty acid storage 
and breakdown, which also promote hepatic lipid accumulation and thus development of 
steatosis.  
However, the vast majority of the cases of NAFLD occur without any notable 
genetic anomalies like those mentioned above; nonetheless, there is still variation in the 
likelihood of developing the disease. In a study of white, African-American, and 
Hispanic populations, which controlled for age and BMI, it was observed that the 
Hispanic population was most likely to present with hepatic steatosis, while African-
Americans were least likely to do so, with the differences reflecting variability in 
abdominal fat accumulation. Interestingly, further analysis of this same group further 
demonstrated that African-Americans developed a higher degree of insulin resistance, 
while still maintaining lower triglyceride levels (Hooper et al., 2011). In this case, the 
differences are not caused by abnormal proteins, but by small variations in normal 
proteins which have just enough of an effect to slightly increase or decrease one’s 
chances of developing disease. Of these, a single nucleotide polymorphism (SNP) in the 
gene for Patatin-like phospholipase domain containing 3 (PNPLA3), also called 
adiponutrin, is of particular note. While many different SNPs in many different genes 
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have been loosely connected to hepatic steatosis, only SNPs in PNPLA3 have been 
strongly associated with variations in hepatic fat content across ethnicities, with similar 
results having been replicated and corroborated in numerous studies over time. Also of 
note is the fact that this SNP was most common in participants of Hispanic descent, who 
are also most likely to develop NAFLD (Hooper et al., 2011). Other genes in which SNPs 
have been associated with NAFLD include MTTP, diacylglycerol acyltransferase 
(DGAT2), and phosphatidylethanolamine N-methyltransferase (PEMT), as well as 
various genes affecting insulin resistance and/or sensitivity, oxidative stress response, 
immunity, and other processes (Hooper et al., 2011). 
Nonetheless, despite recognition of this sort of genetic variability as a contributor 
to disease susceptibility, the most common model of human disease continues to be the 
standard laboratory mouse, Mus musculus. Though there is variation between different 
strains of laboratory mice, individual strains have been highly inbred for years to various 
ends, such as eliminating genetic variants which might affect researchers’ experimental 
results, or selection for various traits, including disease conditions and susceptibilities, 
coat colors, docility, and ease of handling. The genetic homogeneity of the laboratory 
mouse makes it a reliable model for mechanistic studies, and it has been the go-to system 
for the majority of medical and pharmaceutical research (Havighorst et al., 2016). It is 
traditional in research to utilize genetically similar mouse models due to this reduction in 
variables. However, despite its power in providing robust results when selected and 
specific traits and genetic variants are being evaluated, it has limited value in the context 
of naturally existing genetic variation. Unfortunately, this means that for studies 
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involving natural genetic variability between animals, the mouse model’s usefulness is 
limited (Havighorst et al., 2016). 
The human population, unlike laboratory mice, exhibits a great deal of genetic 
diversity. This diversity occurs in genes not just for hair or eye color, but in genes for 
critical components of various cellular pathways. Variations in these genes may not be 
detectable by means other than genetic screening and other similar technologies, but they 
still may play important roles in disease development. As an example of such variation, 
the three different alleles of apolipoprotein E (APOE) are associated with differing 
likelihood of developing diseases such as atherosclerosis, Parkinson’s disease, 
Alzheimer’s disease, and can even affect one’s immune system and therefore ability to 
fight infections. These consequences can be debilitating and even deadly, but the 
different alleles of APOE vary by only two amino acids and would likely not have much 
other drastic effect on the individual outside of relevant challenges (Moretti et al., 2005). 
Small but impactful variations such as this exist throughout the human genome, and only 
a small fraction of these variations have been characterized. 
An additional limitation of the conventionally used inbred mouse models is 
related to the types of genomic manipulations that are performed that are not always 
representative of what occurs in nature and may occasionally be misleading. The vast 
majority of the experimental evidence that causatively associates ER stress with hepatic 
steatosis as well as with other diseases involves the genetic ablation, usually in specific 
tissues, of the particular genes under investigation and subsequently the assessment of the 
phenotypes that develop. Such studies showed that the loss of function of particular UPR 
targets may result in the onset of steatosis underscoring the protective role of the UPR in 
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disease development (Zhu et al., 2015; Yamamoto et al., 2010; Ji et al., 2011; Chen and 
Zhu et al., 2014; Chen and Tseng et al., 2014). Alternatively, other studies identified the 
pro-lipogenic role of certain UPR targets such as CHOP (Rutkowski et al., 2008), 
underscoring the complex integration of the various components of the UPR in the 
development of steatosis.  
These studies, although they clearly establish correlation between specific UPR 
genes and disease, suffer from the fact that genetic ablation of a single loci is rather 
irrelevant biologically and may trigger phenotypes that are qualitatively distinct from 
those occurring naturally, from hypomorphic versions of UPR-associated genes. Indeed, 
it is not uncommon for different quantitative inputs to provide distinct qualitative outputs, 
complicating data interpretation (Garcia and Phillips, 2011). In addition, experimentation 
and disease modeling in genetically homogenous, inbred mice, although a superior choice 
for mechanistic studies, is inadequate in addressing questions regarding the regulation of 
ER stress response in diverse populations which exhibit varying levels of UPR among 
individuals (Wade and Daly, 2005). For example, while UPR is a rather global response 
involving the simultaneous activation of many different transcripts, its deregulation is 
commonly studied at the level of overexpression of specific chaperones upon exposure to 
the stress stimulus without examining if, aside from expression levels of a single target, 
the relative levels as compared with other UPR targets are also associated with 
pathogenicity (Hetz et al., 2013; Gardner et al., 2013). Such questions cannot be 
answered by using inbred mice as a model at which any variation in the response 
recorded is attributed to stochastic differences during the course of the experiment, while 
inherent variation could not be held accountable. 
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The deer mouse, Peromyscus maniculatus, is a genetically diverse model 
organism whose use in medical research is currently restricted due to a lack of available 
tools and the presence of extra variables due to their diversity (Havighorst et al., 2016). 
Native to a large part of North America, the deer mouse has been used extensively  in 
other areas of research, such as animal behavior, coat color genetics, and ethanol 
metabolism (Havighorst et al., 2016). Captive stocks of wild-type deer mice kept at the 
Peromyscus Genetic Stock Center are outbred rather than inbred, meaning that they still 
possess gene variants which affects individual animals’ responses to studies, either subtly 
or overtly. This diversity more closely reflects that of human populations, making the 
deer mouse an ideal candidate for exploring inherent variation between individuals and 
how that variation may affect disease development or progression. 
The overarching theme of the present Thesis was to model for the first time the 
UPR in an outbred, naturally occurring wild type population. Specifically, our goal has 
been to explore and characterize the relationship between ER stress and disease 
susceptibility and progression in a genetically diverse system. We sought to explore the 
outcomes of varying UPR in naturally existing populations, and for this chose to use deer 
mice as our model. In this genetically diverse system, naturally existing quantitative 
variation in the UPR, rather than the qualitative changes typically induced in mice – such 
as genetic deletion or forced overexpression of specific genes of interest – could be 
studied more effectively. Additionally, we asked if the expression of different UPR 
components and genes associated with lipid metabolism is correlated in the liver upon 
administration of a steatosis-inducing diet and whether upon prolonged high-fat diet 
administration this coordination is lost, maintained, or enhanced.  
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The use of deer mice as a model means that experiments are performed on a 
population more comparable to human populations in terms of genetic diversity. The 
combination of in vitro and corresponding long-term in vivo studies performed here has 
not been done in a genetically diverse model organism until now, and this approach has 
led to insight that is more directly relevant to genetically diverse human populations.
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CHAPTER 2: RESULTS 
 
THE PROFILE OF THE UPR VARIES IN FIBROBLAST CULTURES OF DEER 
MICE
Initially, we sought to explore if and to what extent the UPR profile differs among 
individual animals. To address this, primary fibroblast cultures (<7 passages) were 
established during puberty from a genetically diverse population of P. maniculatus 
(n=85, 43 males and 42 females) and the UPR profile was assessed after exposure of 
cultured cells to tunicamycin at 5ug/mL for 5 hours. This dosage and duration of 
treatment has been determined in preliminary studies at which different treatment periods 
and amounts of tunicamycin were tested. As shown in Figure 2.01, high variation in the 
UPR profile was detected as monitored by the baseline levels (upper panel), induction 
levels following tunicamycin exposure (lower panel), and maximal levels (middle panel), 
of a roster of UPR-associated genes that included chaperones BiP, GRP94 and calnexin 
and the ER stress-associated transcription factor CHOP. Since tunicamycin is a rather 
global activator of ER stress and an inducer of the UPR (Li and Lee, 1991), we expected 
to record a positive correlation in the expression of different UPR-related genes in the 
same individuals. Indeed, a strong positive correlation was identified for all pairwise 
comparisons (P≤0.0001, Pearson’s) when maximal levels of expression in tunicamycin–
treated cells were considered (Figure 2.02). Those included clockwise from top (Figure 
2.02) 
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Figure 2.01: Expression of BiP, GRP94, calnexin and CHOP in primary fibroblasts 
isolated at puberty from P. maniculatus (n=85, 43 males and 42 females). Expression 
prior (baseline), after tunicamycin exposure (maximal) at 5ug/mL for 5 hours, and 
ratio max vs. baseline (inducibility) is shown. All expression values had been 
normalized in relation to GAPDH. Each bar represents a different animal. (Adapted 
with permission from Havighorst et al., 2019) 
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Figure 2.02: Coordinated expression of UPR-associated genes in primary fibroblasts 
of P. maniculatus. Pairwise comparisons in expression (arbitrary units) of ER 
stress-related genes after exposure of cells to tunicamycin. R values from Pearson’s 
correlation and P values are shown. All expression values had been normalized in 
relation to GAPDH. (n=85, 43 males and 42 females) (Adapted with permission 
from Havighorst et al., 2019) 
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BiP vs GRP94, GRP94 vs Calnexin, GRP94 vs CHOP, Calnexin vs CHOP, Calnexin vs 
CHOP, CHOP vs BiP, and BiP vs Calnexin. However, when either the baseline levels of 
expression of untreated cells or fold induction (defined as the ratio of maximal to 
baseline) after tunicamycin treatment were analyzed, correlation was decreased and 
reached significance only in specific pairwise comparisons (Figure 2.03). Therefore, we 
concluded that the maximal levels of UPR-associated gene expression likely give the 
most information in terms of UPR induction, and that the intensity of the UPR ultimately 
reflects a generalized systemic response that transcends different branches of the UPR 
rather than a response of specific UPR targets. The fact that maximal expression (after 
tunicamycin treatment) was more informative may also be related to the fact that it 
reflects the maximal capacity for UPR induction, while baseline levels may reflect 
expression in cells that despite the absence of tunicamycin may have undergone some 
stress. The systemic nature of this response is also supported by the observation that the 
expression profile of UPR genes in primary fibroblasts from different animals was similar 
in thapsigargin and tunicamycin treated cells, despite that they induce ER stress by 
alternate mechanisms (Figure 2.04). In line with this is the fact that independent 
preparations of fibroblasts from the left or the right ear rendered similar results for 
GRP94, BiP and calnexin (Figure 2.05). Some variation was detected for CHOP which 
however was insufficient to alter considerably the overall magnitude of the response 
when assessed in comparison with the whole group of animals tested. This variation in 
CHOP is probably related to the fact that CHOP is proapoptotic and therefore is likely 
subjected to strong selective pressure during culture of primary cells (Figure 2.05). 
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Figure 2.03: Pairwise comparisons in expression (arbitrary units) of ER stress-related genes, either at baseline levels 
of expression or fold induction. R values from Pearson’s correlation and P values are shown. All expression values 
had been normalized in relation to GAPDH. (n=85, 43 males, 42 females) (Adapted with permission from 
Havighorst et al., 2019) 
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Figure 2.04: The expression of BiP, GRP94, Cnx and CHOP in fibroblasts from 
different animals exposed to Tunicamycin (TM) or Thapsigargin (TG). Exposure to 
TG was performed at 1μΜ for 5h. Vertical bars indicate SEM from 2 replicas. Animal 
number is indicated. (Adapted with permission from Havighorst et al., 2019) 
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Figure 2.05: UPR expression profile in different fibroblast preparation isolated from 
the left (LT) or right (RT) ear of different animals. Vertical bars indicate SEM from 2 
replicas. Animal number is indicated. (Adapted with permission from Havighorst et 
al., 2019) 
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Noteworthily, this responsiveness of fibroblasts to tunicamycin was progressively 
abolished because at later passage the inducibility decreased (Figure 2.06).    
Comparison between males and females showed no significant difference in the 
profile of the UPR. Yet, a trend for higher intensity was detected in the former. In males, 
the expression of at least 2 UPR genes fell in the top 25th percentile in 16 out of 43 
specimens, as compared to 10 out of 42 in females (P=0.15). These results are consistent 
with previous studies that demonstrate the protective effect of estrogen signaling against 
ER stress (Andruska et al., 2015; Kooptiwut et al., 2014). 
In order to further investigate the relationship between baseline levels, maximal 
expression after tunicamycin treatment, and levels of induction (ratio of maximal to 
baseline), we investigated whether maximal and baseline expression were correlated for 
the different ER stress targets tested. This analysis showed that for BiP (P<0.0001), 
GRP94 (P<0.0001) and CHOP (P=0.0005), but not for calnexin, the maximal levels 
correlated with the baseline levels (Figure 2.07a). This indicates that baseline levels of 
BiP, GRP94 and calnexin proportionally affect their levels of induction after tunicamycin 
administration. In calnexin (P=0.01) and CHOP (P=0.0029), but not for BiP (P=0.81) and 
GRP94 (P=0.53), a reverse correlation between baseline levels and inducibility was 
detected (Figure 2.07b). These observations imply that during stress, different UPR genes 
display a distinct mode of regulation. In some, exemplified by GRP94 and BiP, maximal 
levels are proportional to the baseline levels implying the existence of a not highly 
variable degree of induction. For others such as calnexin, it appears that inducibility is 
negatively associated with the baseline and positively with maximal levels, indicating 
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Figure 2.06: Comparison in the expression profile of BiP, GRP94, CNX and CHOP in 
fibroblasts analyzed at early (2-3) or late (5-6) passage. Vertical bars indicate SEM 
from 2 replicas. Animal number is indicated. (Adapted with permission from 
Havighorst et al., 2019) 
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Figure 2.07: Pairwise comparisons between the baseline expression vs. maximal 
(a) and baseline expression vs. inducibility (b) expression for BiP, GRP94, 
calnexin and CHOP. R values and P values from Pearson’s correlation are 
shown. All expression values had been normalized in relation to GAPDH. (n=85, 
43 males and 42 females) (Adapted with permission from Havighorst et al., 
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that the expression prior to stress determines the extent of stimulation. CHOP follows 
both modes of regulation. 
CHAPERONE INDUCIBILITY IS VARIABLY CORRELATED WITH BLOOD 
GLUCOSE
Because ER stress is associated with multiple pathologies, we next addressed the 
question of whether the variability we observed would lead to differences in disease 
susceptibility between individuals. Of particular interest was the animals’ susceptibility 
to diabetes, since the UPR plays such a prominent role in its pathogenesis. To address 
this, we administered a high-fat, high-sucrose diet, designed to induce diabetes, to 3-
month-old male and female animals whose UPR profiles had been characterized at 
weaning. For six months, we monitored the animals’ blood glucose levels and weights, 
first weekly and then biweekly. Though the animals never became diabetic, we did 
observe correlations between blood glucose levels and UPR gene expression, particularly 
with GRP94 and Calnexin (Figure 2.08). While there was no correlation between GRP94 
and pre-HFD blood glucose levels, GRP94 high responders initially respond robustly to 
dietary challenge, and are able to regulate their blood sugar. While low responders 
experienced a spike in blood sugar on Day 7, high responders maintained a stable blood 
glucose, negatively correlating GRP94 expression and blood glucose (p=0.02). This 
protection, however, begins to taper off until the correlation is reduced below 
significance by Day 35 (p=0.31). By Day 70, however, the two are once again correlated, 
but positively this time (p=0.01), indicating that the adaptive value of high GRP94 
response is high in the short term, but is reduced over the long term to the point that it 
may actually exacerbate the problem. Unlike GRP94, we observed a positive correlation 
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Figure 2.8: Correlation between GRP94/Calnexin and blood glucose shifts over time. 
GRP94 High responders respond robustly to challenge, but this response is exhausted. 
Calnexin High responders have higher overall blood glucose when unchallenged, but 
are better able to respond to challenge. Like with GRP94, the adaptive value of high 
response is short-lived. 
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between Calnexin and blood glucose at Day 0; Calnexin high responders have higher 
overall blood glucose when unchallenged. This correlation had become negative by day 7 
(p=0.14) and had fully reversed by Day 14 (p=0.03), but even this correlation diminished 
by days 28 (p=0.21) and 35 (p=0.47), and remained poor for the duration of the 
experiment; the correlation between Calnexin and blood glucose is ultimately lost under 
prolonged metabolic stress. 
THE OVERALL RESPONSE OF INDIVIDUAL ANIMALS IS CORRELATED WITH 
GLYCEMIC VARIATION
We noted correlations between individual genes and blood glucose levels; 
however, this does not take into account the entire UPR profile of the animal. In order to 
do so, animals were classified as overall high, median, or low responders based on the 
number of genes that were highly expressed (0-4).  This method only considers the 
number of genes being highly expressed; it does not account for specific gene 
combinations which may also be correlated with particular phenotypes. While our sample 
size was not large enough to allow for proper exploration of gene combinations, we 
found that animals which were overall low responders exhibited a greater week-to-week 
variation than overall high responders, which showed very little week-to-week variation 
(Figure 2.09a). Median responders’ week-to-week variation fell between that of the low 
and high responders, suggesting that the overall level of response is indicative of the 
animals’ ability to regulate its blood sugar. While high responders didn’t exhibit great 
fluctuations from week to week, their average blood glucose – like those of the low and 
median responders – did rise 20 points over the six months’ duration of the experiment 
(Figure 2.09b).  
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Figure 2.09: Visualization of week to week glycemic variance, separated by UPR 
profile, (a) represented in terms of % change, (b) represented as average blood 
glucose, and (c) represented as variance. 
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PLASMA LIPID LEVELS CORRELATE WITH THE UPR PROFILE OF PUBERTAL 
FIBROBLASTS EX VIVO
Next, we wanted to test if the profile of UPR recorded in fibroblasts ex vivo 
possesses predictive value for the onset of a chronic pathology linked to ER stress. In 
view of the role of ER stress in the development of metabolic disorders, we studied the 
association of inherent variation in UPR in primary cultures ex vivo with lipid levels prior 
to or after administration of high fat diet. Thus, we measured total cholesterol, low 
density lipoprotein (LDL) and high density lipoprotein (HDL) in the plasma of adult 
animals aged 4-5 months old, before and after short term (2-week) administration of a 
high fat/sucrose diet. We postulated that during this short time-period of high-fat dietary 
intake, no major histopathological damage would occur in the liver, and therefore the 
plasma lipid levels would directly reflect the result of lipid metabolism rather than of 
liver dysfunction. A summary of this analysis is shown in Figure 2.10a while selected 
examples of correlation between total cholesterol (chol) before (pre) or after (post) high-
fat diet administration and BiP, GRP94 and CHOP are shown in Figure 2.10b. Before 
high- fat diet administration all UPR target genes tested showed positive correlation with 
the lipid levels in the plasma suggesting that baseline plasma lipid levels directly follow 
the propensity for individual UPR changes as recorded in primary cell cultures 
established early in life. When this association with plasma lipid levels was specifically 
compared to the baseline levels of UPR targets in cultured cells, their maximal levels 
after tunicamycin exposure, or their relative fold induction, the strongest correlation was 
obtained with the maximal levels of UPR target genes (Figure 2.10a). The corresponding 
baseline levels were correlated with HDL and total cholesterol levels in both GRP94 and 
BiP. Interestingly, relative calnexin expression in tunicamycin-treated cells was signific- 
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Figure 2.10: The UPR profile as recorded in primary fibroblasts is positively correlated with plasma lipid levels. A. R values 
(from Pearson correlation; * = P<0.05) between prior (baseline), after tunicamycin exposure (maximal), and ratio max vs. 
baseline (inducibility) for BiP, GRP94, Calnexin, or CHOP and lipid levels in the plasma of 4-5 month animals (n=15). Lipid 
levels were assessed in animals receiving regular or high-fat/sucrose diet for 2 weeks. B. Representative examples of correlation 
between total cholesterol (chol) before (pre) or after (post) high-fat diet administration and BiP, GRP94, and CHOP in pubertal 
fibroblasts after exposure to tunicamycin. *=P<0.01, Pearson’s). (Adapted with permission from Havighorst et al., 2019) 
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antly correlated with HDL and total cholesterol levels, but this was not the case with the 
other tested UPR targets.   
In challenged animals that had received high-fat diet for 2 weeks, plasma lipid 
levels increased (Figure 2.11g), but BiP levels in culture ceased to be associated with 
lipid levels in the plasma as they were prior to diet-induced challenge (Figure 2.10). 
However, the maximal levels of CHOP and calnexin levels continued –with the exception 
of calnexin and HDL - to show association with the plasma lipid levels in the same way 
as they did prior to high-fat diet administration. It is possible that while BiP is mostly 
associated with basal lipid metabolism, under conditions of metabolic challenge CHOP 
and calnexin are engaged more. A role in promoting lipid accumulation has been 
demonstrated for CHOP (Rutkowski et al., 2008); however, we are unaware of a similar 
association between calnexin and lipogenesis.  
THE PROFILE OF BIP EXPRESSION IN CULTURED CELLS IS DISTINCT IN 
HIGH-ALTITUDE DEER MICE
Adaptation at high altitudes involves reprogramming of the animals’ metabolic 
program to satisfy, among other demands, the elevated demands for thermogenesis and 
insulation (Havighorst et al., 2019). Therefore, we explored if the differences in the UPR 
profile recorded in P. maniculatus have ramifications in the adaptation to different 
environments. Analysis of animals from a colony established in the past from ancestors 
captured at high altitudes (SM2 population) (Vrana et al., 2014) showed that, in general, 
these animals exhibited more intense UPR than the low altitude population (BW 
animals), as evaluated by the number of genes that are in the top 50th, 25th or 5th 
percentile of the combined BW and SM2 population (Figure 2.11). 
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Figure 2.11: Differences in the UPR profile in primary fibroblasts between high 
(SM2 population, n=24) and low (BW population, n=61) altitude deer mice. a. 
Percentage of animals in each of the SM2 or BW populations that have at least 1 UPR 
gene in the highest 50th percentile of the total population. P value is shown (chi-
square test). b. Percentage of animals in each of the SM2 or BW populations that 
have all 4 UPR genes in the highest 25th percentile of the total population. P value is 
shown (chi-square test). c. Percentage of animals in each of the SM2 or BW 
populations that have 3 or 4 UPR genes in the highest 5th percentile of the total 
population. P value is shown (chi-square test). The corresponding distribution for the 
number of genes in each analysis is shown in d, e and f, on the right panel. For these 
analyses maximal expression was considered. g. Average lipid levels in SM2 (n=5) or 
BW (n=10) prior to or after high-fat diet administration for 2 weeks. P values 
(students t-test) are shown. (Adapted with permission from Havighorst et al., 2019) 
 
 
35 
For this analysis the percentage of animals in each of the SM2 or BW populations 
that have at least 1 UPR gene in the highest 50th percentile (Figure 2.11a), that have all 4 
UPR genes in the highest 25th percentile (Figure 2.11b), or that have 3 or 4 UPR genes in 
the highest 5th percentile (Figure 2.11c) of the total population are shown. The 
corresponding distribution for the number of genes in each analysis is shown in Figure 
2.11d, Figure 2.11e and Figure 2.11f, respectively. 
In view of the positive correlation between UPR genes and plasma lipids, a 
testable hypothesis is that high altitude animals had elevated plasma levels of lipids. 
Indeed, the levels of LDL and to a lesser extent of total cholesterol – but not of HDL – 
were elevated both prior to and after high-fat diet administration (Figure 2.11g). It is 
plausible that enhanced UPR expression represents an adaptation that facilitates enhanced 
lipogenesis at high altitude populations that in turn may satisfy the increased needs for 
thermogenesis and insulation in rodents (Vaillancourt et al., 2009; Cheviron et al., 2012) 
and humans (Temte 1996; Hirschler et al., 2012; Perrett et al., 2002).   
THE UPR PROFILE  EX VIVO PREDICTS HEPATIC STEATOSIS INDUCED BY 
HIGH-FAT DIET
We subsequently tested if the profile of UPR ex vivo predicts the onset of chronic 
diseases such as hepatic steatosis that are caused by long-term administration of high 
fat/sucrose diet. Therefore, a cohort of animals, aged 3 months, whose UPR profile had 
been recorded at puberty were subjected to high fat/sucrose diet for 6 months and 
analyzed for evidence of fatty liver disease. Since UPR expression is generally 
coordinated, this analysis involved animals exhibiting low coordination to facilitate 
assessment of the individual genes’ predictive value. Although none developed diabetes, 
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elevated baseline insulin levels, indicative of the onset of insulin resistance, were 
positively associated with high baseline levels of GRP94 (not shown). Histopathological 
analysis upon termination of the study showed that 50% of the animals exhibited 
steatosis, occasionally associated with portal inflammation of variable degrees (Figure 
2.12a,b) that was correlated with the baseline levels of calnexin in the fibroblasts 
(P=0.045) (Figure 2.12c). No lobar inflammation, ballooning degeneration of the 
hepatocytes, or fibrosis of the stroma was observed. Analysis of steatosis onset, in 
concert with GRP94 expression ex vivo, identified the latter as a protective factor for 
disease development: The majority of the animals with steatosis (87.5%) had maximal 
GRP94 levels in culture at the lower 50th percentile as opposed to only 12.5% of the 
animals that developed steatosis and had maximal GRP94 at the higher 50th percentile 
(P=0.0027, chi-square test) (Figure 2.12c). It is to be noted that both baseline and 
maximal levels of GRP94 exhibited positive correlation with HDL and total cholesterol – 
but not LDL - levels prior to high-fat diet administration but this association was 
abolished after 2 weeks of high fat/sucrose diet. As opposed to GRP94 that was 
protective, high maximal BiP expression (P=0.017) in fibroblasts and inducibility of 
CHOP (P=0.033) were predictive for higher sensitivity to steatosis (Figure 2.12). To that 
end, the increased incidence of steatosis in the animals with higher BiP expression could 
be the trade–off for the enhanced lipogenesis that may be beneficial at high altitudes.  
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Figure 2.12: Long-term administration of high-fat diet causes metabolic pathologies at 
variable degree in P. maniculatus (n=16). a. Macroscopic and necropsy images 
showing animals with minimal (upper panel) or high (lower panel) fat accumulation 
after administration of high fat/sucrose diet for 6 months. b. H&E –stained sections of 
livers from mice showing minimal or no evidence of pathology (upper panel), high 
degree of hepatic steatosis (lower left) or portal inflammation (lower right). Yellow 
arrows indicate cells accumulating high amount of fat and yellow asterisks indicate 
portal inflammation. c. Correlation between steatosis (recorded in 8 out of 16 animals) 
or portal inflammation (recorded in 8 out of 16 animals) and whether the expression of 
the corresponding UPR-related gene was assigned to the top 50th (H50) or bottom 50th 
(L50) percentile in the animals tested. P values (chi-square test are indicated). 
(Adapted with permission from Havighorst et al., 2019) 
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ACTIVATION OF UPR AND VARIABLE SENSITIVITY TO STEATOSIS IN P. 
MANICULATUS THAT RECEIVED HIGH-FAT DIET FOR 6 MONTHS
Initially we explored if outbred deer mice are sensitive to diet-induced hepatic 
steatosis. To that end, animals were given a high-fat, high-sucrose diet for 2 weeks or 6 
months and monitored the onset of pathology in the liver. While high-fat diet for 2 weeks 
did not cause pathology, prolonged high-fat diet administration for 6 months resulted in 
the development of hepatic steatosis in about half of the animals (6 out of 13) (Figure 
2.13). No lobar inflammation, ballooning degeneration of the hepatocytes, or fibrosis of 
the stroma was observed. Then we analyzed the hepatic expression levels of UPR genes 
BiP, GRP94, calnexin and CHOP, of enzymes linked to lipid metabolism: hepatic lipase 
(HL) (Perrett et al., 2002), LDL receptor (LDLR) (Rudling et al., 1990) and autophagy 
genes LAMP1 (Eskelinen 2006), ATG5 (Rouschop et al., 2010) and ATG14 (Zhao et al., 
2015). Both males and females (about 50% each) were included in both groups but no 
gender-specific differences were recorded. Comparison in the hepatic expression of the 
UPR genes between experimental groups showed that only CHOP was significantly 
upregulated in all groups that received HFD for 6 months as compared to those that 
received it for 2 weeks only (Figure 2.14). Similar profile was exhibited by LDLR and 
LAMP1 while HL was overexpressed in the animals that received HFD for six months 
but did not developed steatosis (Figure 2.14). No considerable difference was observed 
between the animals that developed steatosis and those that did not, which suggests that 
the upregulation of these transcripts is a consequence of the lipid-rich diet and not of 
steatosis. Not surprisingly, high variation in the levels of genes’ expression was recorded  
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Figure 2.13: H&E stained sections of liver parenchyma showing intracytoplasmic 
accumulation of lipids in hepatocytes. In the upper panel, a specimen with only a few 
cells having fat vacuoles is shown while in the lower panel, a specimen with most of the 
cells having fat vacuoles is shown, indicative of extensive liver steatosis. 
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Figure 2.14: Hepatic expression of UPR genes BiP, GRP94, Calnexin and CHOP, 
lipid metabolism enzyme hepatic lipase (HL), LDL receptor (LDLR) and autophagy 
genes LAMP1, ATG5, and ATG14 in animals that received the high-fat diet for 2 
weeks (n=14) or 6 months (n=13). Expression levels in animals that received HFD 
for 6ix months and developed or did not develop steatosis are shown. P values (one-
way ANOVA by applying Tukey’s multiple comparison test) between experimental 
groups are shown. Error bars indicate SEM. 
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between the different animals which is due to their genetic heterogeneity and the 
stochastic nature of disease development. 
COORDINATION OF CHAPERONE EXPRESSION IS MAINTAINED DURING 
HIGH-FAT DIET ADMINISTRATION
The UPR is a concerted cellular response that engages multiple biochemical 
pathways simultaneously. Therefore, it is conceivable that the levels of each individual 
chaperones will be correlated, regardless of their differential intensity between individual 
animals. To test this hypothesis we performed pairwise comparisons in the expression 
levels of UPR genes in animals that had received high-fat diet for 2 weeks and 6 months. 
A summary of the results is shown in Figure 2.15. After only 2 weeks in the high-fat diet 
a high degree of correlation was attained for all pairwise comparisons of the chaperones 
tested between BiP, GRP94 and calnexin, and this correlation was maintained in the 
livers of animals that received a high-fat diet for 6 months. Thus, although long term 
administration of high-fat diet and thus of ER stress induction can modulate individual 
chaperones’ expression, their coordination is retained. The expression of CHOP was not 
coordinated with any of the chaperones tested (Figure 2.16) despite that its overall 
expression was significantly elevated. 
UPR GENES EXHIBIT A DISTINCT PROFILE OF COORDINATION WITH 
LIPOPHAGYMARKERS, LIPID METABOLISM ENZYMES DURING HIGH-FAT 
DIET ADMINISTRATION
Because UPR is associated with both lipophagy and lipid metabolism, we 
assessed if the expression of ATG5, ATG14 and LAMP1 (autophagy markers, Figure 
2.17) or HL and LDLR (lipid metabolism, Figure 2.18) is coordinated. The analysis 
showed that among the autophagy markers ATG5 was coordinated with the expression of  
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  Figure 2.15: Correlation in the hepatic expression between BiP, GRP94 and 
Calnexin in animals that received high-fat diet for 2 weeks (n=14) (a) or 6 months 
(b) (n=13). High correlation is attained in both the 2 weeks and the 6 months-treated 
groups. Each dot corresponds to a different animal. Levels of each transcript are 
expressed in arbitrary units following normalization with GAPDH. R values are 
shown. All correlations were significant (P<0.05, Pearson’s correlation).  
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Figure 2.16: Correlation in the hepatic expression between CHOP and each of BiP, 
GRP94 and Canexin in animals that received high-fat diet for 2 weeks (n=14) (a) or 
6 months (b) (n=13).  Although a positive trend can be recognized statistical 
significance was not attained. 
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Figure 2.17: Hepatic expression of UPR genes BiP and GRP94 in relation to 
lipophagy markers ATG5, ATG14 or LAMP1 in animals that received high-fat diet 
for 2 weeks (n=14) (upper panel) or 6 months (n=13) (lower panel). Levels of each 
transcript are expressed in arbitrary units following normalization with GAPDH. Only 
ATG5 exhibited positive correlation with both BiP and GRP94 (P<0.05, Pearson’s). 
R values are shown. 
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Figure 2.18: Hepatic expression of UPR genes BiP and GRP94 in relation to HL 
and LDLR in animals that received high-fat diet for 2 weeks (n=14) (upper panel) 
or 6 months (n=13) (lower panel). Levels of each transcript are expressed in 
arbitrary units following normalization with GAPDH. Positive correlation was 
recorded for HL in 6 months (P<0.05, Pearson’s). R values are shown. 
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either BiP or GRP94 (as well as calnexin, not shown) in both the 2 weeks and the 6 
months high-fat diet group (Pearson’s, P<0.05).  
Of the lipid metabolism genes, HL was expressed in a coordinated manner with 
both BiP and GRP94 both in the 2 weeks and the 6 months high-fat diet group and 
attained significance in the latter (P<0.05, Pearson’s). 
HL ABOLISHES ITS COORDINATION WITH UPR GENES ONLY IN THE 
STEATOSIS GROUP
The fact that the 6 months high-fat diet group included both animals that developed 
steatosis (n=6) and animals that did not (n=7), in combination with the fact that some 
differences were seen in the group that received the high-fat diet for 2 weeks or 6 months 
raised the possibility that the heterogeneity in pathology may contribute to the variation 
in the coordination profiles recorded. To explore this possibility further we assessed the 
extent of coordination, independently in the steatosis and the non-steatosis group in 
comparison with that of the 2 weeks group (n=14) and the 6 months group cumulatively 
(n=13). For this analysis we used Spearman’s correlation that is more appropriate for 
monotonic relationships especially when small number of samples are included. The 
results are shown in Figure 2.19. UPR genes retained their correlation profile in all 
groups tested, regardless of whether steatosis developed (Figure 2.19). The same pattern 
was also exhibited by ATG5 that had positive correlation with the UPR genes in all 
experimental groups. LDLR did not show any evidence of correlated expression in any of 
the groups studied suggesting that despite its upregulation in the long term HFD-group 
(Figure 2.14), its regulation is independent of the UPR and does not signify steatosis 
development. Interestingly, HL and LAMP1 retained a positive correlation with UPR that 
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was however reversed in the livers with steatosis. ATG14 exhibited the reverse profile, 
albeit at a lesser extent, as livers without steatosis after 6 month HFD administration 
showed reduced coordination with the UPR. 
HL IS INHIBITED BY ER STRESS 
The inverse correlation of LAMP1 with UPR genes only in the steatosis group is 
not surprising considering that LAMP1 is a lysosomal marker and that lipophagy is 
generally impaired in steatosis (Andruska et al., 2015; Kooptiwut et al., 2014; Vrana et 
al., 2014). With HL however, this association (Figure 2.20a) was intriguing in view of the 
controversial of this enzyme in steatosis development (Chiu et al., 2010; Andres-Blasco 
et al., 2015). To test if HL is regulated by ER stress, rat hepatoma (H-411-EC3) cells 
were exposed to tunicamycin (2.5ug/uL or 5ug/uL), and chaperone expression as well as 
expression of HL were evaluated. As expected BiP, GRP94, CNX and CHOP were 
activated during both 5h and 24h tunicamycin treatment confirming that canonical UPR 
is induced (Figure 2.20b). Under these conditions, HL exhibited a moderate induction at 
5h, but a strong reduction at 24h. This reduction was apparently dose dependent, with 
greater decrease occurring with 5ug/usL than with 2.5ug/uL tunicamycin (Figure 2.20c). 
We may postulate that longer exposure to tunicamycin induces severe ER stress which in 
turn mimics the state of the steatotic livers in which negative correlation between HL and 
UPR genes was recorded. However, under short-term exposure to tunicamycin – when 
presumably ER stress is mild – a moderate activation of HL is seen which simulates the 
state of the livers without steatosis. 
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Figure 2.19: Correlation matrix in the hepatic expression between BiP, GRP94, 
Canexin, CHOP, LAMP1, ATG5, ATG14, HL, and LDLR in the livers of animals 
that received lipid-rich diet for 2 weeks (n=14) (a), 6 months cumulatively (n=13) 
(b), only those that did not developed steatosis (n=6) (c) and those that did (n=7) 
(d). R values (correlation coefficient) from Spearman’s correlation are shown (*, 
P<0.05). Yellow and red squares outline genes that respectively retained or 
abolished their coordination with the UPR genes in the livers with or without 
steatosis.  
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Figure 2.20: Regulation of HL by ER stress. a. Opposite correlation between HL and 
UPR genes in livers with and without steatosis. b. Expression of BiP, GRP94, CNX 
and CHOP in H-411-EC3 cells exposed to tunicamycin (0 or 5 ug/ml) for 5h or 24h. c. 
Dose-dependent inhibition of HL expression during ER stress. Results had been 
normalized with GAPDH and are expressed in arbitrary values (AU). 
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CHAPTER 3: DISCUSSION
While the linearity in the expression of UPR-associated genes has been studied 
extensively by induced qualitative changes in gene expression, whether the response to 
ER stress exhibits coordination and variability among individuals remains inadequately 
studied. In the present study, we used genetically diverse deer mice as a model to record 
the profile of the UPR in cultured primary cells isolated at puberty. Our analyses showed 
that UPR induction at the mRNA level was highly variable between different animals, yet 
a high degree of coordination was maintained in the expression levels of individual 
targets; some animals exhibited a more intense response to ER stress while others 
displayed a milder response. The importance of this difference in the adaptation of 
animals in different environments is suggested by the observation that the high-altitude-
originating SM2 stock of deer mice exhibit a more intense UPR than the low-altitude-
originating BW stock. This tendency was apparent regardless of the cut-off of the gene 
number that were considered. It is noted, though, that this association may reflect founder 
effects during the establishment of SM2 colonies of P. maniculatus. To eliminate this 
possibility, wild caught animals should also be used to validate this finding. Nonetheless, 
the presence of different alleles with regards to the polymorphisms in BiP promoter 
between the 2 different stocks supports the notion that the populations are genetically 
distinct and that certain differences in the regulatory regions of UPR genes such as BiP 
may contribute to the distinct profile of the UPR in these stocks (Havighorst et al., 2019) 
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Whether the UPR variation observed in vitro reflects varying efficiency of protein 
folding, or an altered response during challenge, remains unknown. Although neither 
possibility can be excluded formally, our data are mostly aligned with the latter 
possibility. We postulate that if the differences recorded here were primarily due to the 
inherent, varied ability of the individuals for protein folding, then no association between 
baseline expression and maximal expression would have been recorded, since the 
baseline levels would be assumed to be different but the maximal levels should have 
remained similar. In addition, fibroblasts were analyzed in vitro, after multiple passages 
in the petri dish, decreasing the possibility that systemic factors might have caused the 
differences recorded. Formally, the possibility that systemic factors might have caused 
epigenetic changes in the fibroblasts cannot be ruled out, but this appears rather unlikely. 
In order to systematically though address this, experiments should be designed to assess 
the abundance of misfolded proteins independently of UPR induction and then test if and 
at which extent they (UPR genes’ levels and accumulated unfolded proteins) correlate 
with each other.  
The availability of individual animals with variable response to UPR allowed us 
to explore if inherent variation in UPR is associated with metabolic disease and 
deregulation of lipid homeostasis, conditions that are highly relevant to ER stress. 
Therefore, we assessed the animals’ blood glucose on a weekly basis, and additionally 
assessed the animals’ lipid levels both prior to and after high fat diet administration. 
While the animals did not become diabetic, we did observe an apparent difference in the 
abilities of high and low responders to maintain a stable blood glucose, which high 
responders appeared to do far more effectively. Additionally, we noted a shift in 
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correlation between GRP94/Cnx expression and blood glucose; this is likely a reflection 
of the increasing stress and metabolic changes occurring due to high-fat diet. It is noted 
that although isoflurane in known to induce hyperglycemia, administration of isoflurane 
is unlikely to have affected our results, as animals were not exposed to isoflurane except 
immediately prior to sacrifice. Weekly blood collections were performed without 
anesthetic of any sort, and blood collected for lipid analysis was collected via 
submandibular puncture prior to anesthesia and subsequent sacrifice. Additionally, 
isoflurane was applied to the lipid profile control groups as well, which were 
unchallenged and should not have exhibited alterations to their cholesterol profile. It is 
emphasized that the administration of the high fat diet occurred in adults, beginning two 
months after the characterization of the fibroblasts that occurred at puberty. Our results 
suggest that the UPR profile of cultured fibroblasts isolated early in life is linked to the 
onset of metabolic pathologies at the organismal level. With regards to the lipid levels in 
the plasma, the ex vivo levels of all 4 genes tested showed, independently, a positive 
association with the baseline plasma lipid levels underscoring the link between ER stress 
and lipid metabolism. After high-fat diet administration, this association persisted only 
for CHOP and calnexin, implying that these UPR genes increase in expression 
particularly after diet-induced stress.  
Prolonged administration of high-fat diet and induction of steatosis in a subset of 
the animals facilitated assessment of the predictive value of individual UPR-associated 
genes in disease development. This considerable variation in steatosis development is 
seen only in the outbred Peromyscus used here because in laboratory mice, prolonged 
administration of high fat diet, albeit variably among different inbred strains, induces 
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steatosis rather uniformly within the animals of the same strain while some variation 
exists only to the portion of the liver exhibiting evidence of disease (Rudling et al., 1990; 
Eskelinen 2006; Rouschop et al., 2010; Zhao et al., 2015). 
Animals for which UPR genes were not coordinated, especially BiP and GRP94, 
were subjected to a high-fat diet; this allowed us to appreciate the contribution of each 
individual gene. Analysis showed that the UPR profile in fibroblasts collected early in the 
animal’s life could be used to predict the animal’s susceptibility to diet-induced hepatic 
steatosis. An intriguing finding was the protective role of GRP94 against steatosis, 
despite the positive association of this gene with plasma lipid levels, implying the 
operation of a predictive factor capable of dissociating hyperlipidemia with hepatic 
disease. A role for GRP94 in suppressing liver cancer has been proposed (Chen and 
Tseng et al., 2014; Chiu et al., 2010), but no evidence for the direct involvement of 
GRP94 in hepatic steatosis is available, which may point to a novel action of this 
chaperone in lipid metabolism.  
With regards to BiP, our analysis showed that higher BiP expression in the 
fibroblasts was associated with an increased risk of developing hepatic steatosis. It is 
noteworthy that the specific deletion of BiP in hepatocytes promotes steatosis in 
laboratory mice (Mus), implying a protective role for BiP in disease development (Ji et 
al., 2011; Chen and Zhu et al., 2014). It is conceivable that this contradiction reflects the 
pleiotropy of BiP function and its cumulative role in lipid metabolism beyond the liver. 
Enhanced expression of BiP in the liver may thus be protective, as pointed out by the 
mouse studies. However, this benefit could be counteracted by its presumably negative 
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role in other peripheral tissues. Consistent with this observation, it has been demonstrated 
that systemic administration of chemical chaperones alleviates hepatic steatosis in rodent 
models of the disease (Andres-Blasco et al., 2015). Furthermore, the transcription factor 
XBP1 that is activated during the UPR has been shown to possess lipogenic activity 
(Chiu et al., 2010), even though an anti-lipogenic role has also been shown (Rouschop et 
al., 2010). Another plausible explanation is that the genetic ablation of BiP in vivo 
produces phenotypes that may be qualitatively distinct from the reduction of BiP 
expression over time in response to the high-fat diet, as we observed in the genetically 
diverse experimental animals used here. The cascade of events triggered by the deletion 
of BiP and other UPR-associated genes in mice may cause phenotypic manifestations that 
are not highly relevant to the naturally occurring versions of hypomorphic BiP alleles 
seen in deer mice, or to physiological alterations to BiP expression which occur due to 
challenge (Havighorst et al., 2019). This may also explain the apparent discrepancy that, 
depending on the model, both lipogenic and antilipogenic activities for the same UPR 
gene may be revealed (Lee et al., 2008; Herrema et al., 2016).  
We found calnexin’s involvement to be intriguing. While it exhibited a similar 
predictive activity to CHOP for lipidemia, no association with hepatic steatosis was 
observed. It is likely that this reflects a shared regulation between CHOP and calnexin, or 
a direct regulatory association between them during metabolic stress. 
Whether the UPR variation observed here, which we recorded at the mRNA level, 
also reflects similar variation at the protein level remains to be established. 
Unfortunately, the absence of Peromyscus-specific antibodies or antibodies that 
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adequately work on this genus to allow quantification of protein levels precludes this 
analysis at this point. In addition, we note that mRNA levels as assessed here should 
rather be viewed as indicators of differential activation of the UPR. Protein levels may or 
may not directly follow changes to mRNA levels. However, in this case, an additional 
level of complexity will be introduced: that of posttranslational modification which might 
have masked the correlation between UPR gene expression and pathophysiological 
parameters. As such, assessing protein levels may be useful for mechanistic studies 
addressing the role of individual chaperones, yet activation of the UPR could not be 
monitored accurately by evaluating protein levels. 
We observed that different ER stress-linked genes were generally associated with 
distinct parameters, either biochemical or histological. However, depending on the 
specific gene-pathology combination, the highest correlations could be found in the 
baseline, induction levels, or maximal levels. It is likely that while baseline levels reflect 
a chronic stress state, exemplified by GRP94 and BiP levels, the inducibility and 
especially maximal levels instead reflect acute stress and are exemplified by all 4 ER 
stress-related genes analyzed here. The power of the protein processing machinery to 
operate as a modifier of disease outcomes has been shown recently by the demonstration 
that the activity of HSP90, the cytosolic paralogue of GRP94, determined the severity of 
the cancer predisposition syndrome Fanconi anemia (Taipale et al., 2014). 
Collectively, the ability of the UPR profile to predict the outcome of ER stress-
associated pathologies later in life shows that the UPR intensity reflects a systemic 
response rather than a reaction of isolated organs and tissues. It is also plausible that the 
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organismic level responses recorded here to reflect the actual contribution of fibroblasts 
that remain the most abundant cell type in the body. Nevertheless, it is conceivable that 
by analyzing an appropriate selection of chaperones or combinations of UPR genes, the 
onset of different ER stress-related pathologies may be predicted. It is likely that, by 
using this platform consisting of different stressors in outbred populations, unforeseen 
links between specific ER stress-associated genes and various diseases could be revealed. 
Finally, the role of inherent variation of the UPR in the adaptation to different 
environments needs to be elucidated.  
In order to maintain homeostasis, cells respond to stressors by altering their 
transcriptional profile in such a manner that the expression of genes that belong to the 
same transcriptional networks remains coordinated. Therefore, changes in gene 
expression affect not only an individual gene, but also any genes that might be co-
regulated along with it. It is conceivable that, during disease development, some 
transcripts will deviate from this coordinated expression, including some that might be 
causatively linked to the disease. This information could provide insight into disease 
pathogenesis and also aid us in the identification of disease-relevant targets.  
The present animal model also allows exploration with regards to the involvement 
of UPR in the liver, in  the pathogenesis of hepatic steatosis. By using outbred, 
genetically diverse deer mice as our model, and by placing them on a high-fat diet for a 
short period of time or long term, under conditions in which only a fraction of the 
animals developed hepatic steatosis (Untergasser et al., 2012) we analyzed the UPR in 
the liver. We hypothesized that liver samples from these groups would respectively 
 57 
reflect conditions of short-term stress, chronic stress but with homeostasis maintained (no 
steatosis), and ultimately chronic stress when homeostasis is abolished and pathology 
(steatosis) emerges. No animals receiving regular chow were included in the analyses 
because they do not develop steatosis (not shown), their ER is unchallenged, and UPR is 
minimal. Because our analysis focused on differences between steatotic and nonsteatotic 
animals exposed to identical conditions, we postulated that analysis of coordination in 
gene expression in control animals would be meaningless. 
We performed our studies in outbred deer mice as opposed to conventional inbred 
mice to be able to record the degree of coordination and eventually the loss of such 
coordination in a genetically diverse wild type population. The transcriptional analyses 
involved a panel of genes associated with the UPR, a nodal transcriptional response 
pathway with an established relationship with liver dysfunction and hepatic steatosis, and 
genes linked to either liver metabolism (LDLR, HL) or lipophagy (LAMP1, ATG5 and 
ATG14). In the absence of reliable Peromyscus-specific antibodies, quantification of 
protein levels could not be performed. However, mRNA levels should rather be viewed 
as precise indicators of differential activation of the UPR and thus assessing them 
provides reliable means to evaluate its differential profile in different individuals.  
Our analysis showed that, compared to the short-term high-fat diet administration, 
long-term high-fat diet caused a significant activation of CHOP as well as of LAMP1, 
HL and LDLR. Yet, high variation in gene expression was recorded, which is likely due 
to the genetic diversity of the animal model. Importantly, no differences in the expression 
levels between the livers that developed steatosis and those that did not were recorded 
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suggesting that expression levels of individual transcripts are unable to discriminate the 
disease.  
However, when expression was co-analyzed for different transcripts, we realized 
that the activation of the UPR shortly after the induction of high-fat diet-induced stress is 
characterized by a coordinated expression of the various chaperones which retain their 
ability to respond proportionally, though variably, in the different animals tested. This 
coordination was maintained in conditions of prolonged exposure, despite the fact that 
differences in the profile of coordination could be seen. Specifically, a weak trend for 
loss of coordination was unveiled between the short-term diet group and that of long-term 
administration. In the latter group, however, animals with and without steatosis were 
included in the same analysis with no difference in the trends observed between these 
groups. Under these conditions, CHOP exhibited the weakest coordination with the other 
UPR-associated genes, an observation that probably reflects the complex regulation of 
this transcription factor beyond ER stress. 
Of the lipophagy markers, only ATG5 was coordinated with UPR genes GRP94 
and BiP, and this profile was maintained regardless of disease onset. LAMP1, despite 
being consistently upregulated under long-term high-fat diet, exhibited only insignificant 
coordination with the UPR implying that unlike ATG5 and ATG14, regulation of 
LAMP1 is not tightly linked to ER stress. Similarly, of the genes associated with lipid 
metabolism, only HL showed coordination with both BiP and GRP94, implying a 
potential causative link between this enzyme and the UPR. The specific role HL in 
steatosis progression, especially in the context of ER stress induction is further marked by 
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its loss of coordination with UPR genes in the specimens that developed steatosis. 
Comparison of the degree of coordination between all lipophagy and lipid metabolism 
genes with the UPR-associated genes in the livers that received high-fat diet showed that 
HL was the only gene that exhibited consistently high coordination, and that this 
coordination was lost and indeed reversed, only in the specimens that developed steatosis. 
Thus, it is not the chronic administration of the high-fat diet that is linked to this loss of 
coordination, but rather the development of steatosis. Therefore, we hypothesize that HL 
is regulated by the UPR only in the context of homeostasis, but this association is lost 
when pathology emerges. In line with this notion are previous observations in genetically 
modified mice at which genetic ablation of HL may result in opposing findings with 
regards to steatosis according to which both a protective and promoting role has been 
reported (28,29). To that end it is conceivable that it is not the activity of HL that is 
linked to steatosis but rather its degree of coordination with the UPR and other possible 
targets, that depending on the experimental system may be associated with both induction 
and inhibition of ER stress, shifting its coordination with HL to either direction.  
We further validated the regulation of HL during ER stress by exposing 
hepatocytes to tunicamycin, which showed that prolonged treatment inhibited HL 
expression, while UPR target genes were induced. We postulate that during short-term 
exposure, when ER stress is moderately activated, the hepatocytes initiate the adaptive 
UPR that retains homeostasis and thus HL is co-induced with the UPR target genes, a 
state that simulates that of the liver tissues in animals without steatosis. When steatosis 
develops and homeostasis is abolished, on the other hand, the activation of HL by the 
 60 
UPR is lost, as happens with the hepatocytes in culture at which HL is inhibited during 
prolonged ER stress. 
These results have important implications in disease management suggesting that 
at least for complex multifactorial diseases, instead of pursuing specific targets for 
therapeutic intervention it is rather their relative abundance, in concert with other 
members of the biochemical response in question, that bears value as a disease causing 
agent. Because this balance seems to be important, it may actually do more harm to 
inhibit specific UPR-related genes, even if said gene has been experimentally linked to a 
disease; in fact, doing so may itself lead to the development of disease. 
It is conceivable that analyses such as the one described here, towards more 
disease entities and additional gene targets, may be useful in assembling detailed gene 
networks and demonstrating how their deregulation is abolished during disease 
pathogenesis. Such an approach may be particularly useful in developing innovative 
therapeutic strategies, in assembling transcriptional networks and elucidating how they 
operate in physiology and pathology, and in assigning particular transcripts to given 
biochemical responses. 
Collectively, the present study explored for the first time the regulation of the 
UPR in a genetically diverse population and evaluated the implications of this regulation 
and of its dysregulation in metabolic diseases, like hepatic steatosis. Findings of the 
present research will likely find application in biomedical research.  
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CHAPTER 4: METHODS AND MATERIALS 
 
FIBROBLAST CULTURE AND TUNICAMYCIN TREATMENT
Fibroblasts were isolated from ear punches collected from juvenile mice during 
routine weaning and marking procedures at the Peromyscus Genetic Stock Center 
(PGSC). These ear punches were washed for 2 minutes in 2mL 70% EtOH (Decon) 
before being placed in 1mL sterile RPMI-1640 + 10% FBS + 500 u/mL Penicillin + 500 
uL/mL + .292mg/mL L-Glutamine (all HyClone) (hereafter “complete RPMI”), which 
had previously been aliquoted into sterile 1.5mL tubes under a hood, ensuring sterility 
until tissue collection. Ear punches were macerated using sterile surgical blades 
(GLASSVAN; blade size 24) andtreated with 1mL collagenase I (Sigma-Aldrich, 
100U/ml) dissolved in plain RPMI for 1 hour. After 1 hour, the collagenase in the media 
was inactivated by the addition of complete RPMI (at least 2mL per mL collagenase 
solution). The following day, an additional 2mL of complete RPMI was added to boost 
the concentration of FBS in the culture. Remaining tissue fragments were removed via 
vaccuum from the culture once cells were visible, typically three days following 
collagenase treatment, during media change. Cells were subsequently cultured in 
complete RPMI. For cell passage, we removed old media, washed the cells with sterile 
PBS, then treated them with porcine trypsin (HyClone) for 5 minutes when cells were at 
90% confluency or above. They were then passed to larger plates, without discarding any 
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cells, to 45% confluency or above. Fibroblasts were passed no more than 5 times before 
tunicamycin treatment, with the exception of cells used for the high-passage control, 
which were treated at passages 2 and 6. For tunicamycin treatment, cells were split into 
6-well plates (VWR) at 300,000 cells/well, and left for 24 hours to recover. After 24 
hours, tunicamycin (Sigma-Aldrich) dissolved in DMSO (Sigma-Aldrich) was added to 
the media to a concentration of 5ug/mL for 5 hours, immediately followed by RNA 
extraction (procedure described below). For thapsigargin treatments, an identical 
procedure was followed, with the exception of the addition of thapsigargin (Sigma-
Aldrich) dissolved in DMSO to a concentration of 1μΜ. 
H-411-EC3 rat hepatoma cells (courtesy of Karen Barbour, USC Department of 
Biological Sciences, Center for Colon Cancer Research) were cultured using MEM 
(Corning) + 10% FBS + 500 u/mL Penicillin + 500 ug/mL Streptomycin + .292mg/mL 
L-Glutamine + 5mL essential amino acid solution (Corning) (“complete MEM”), and 
passed when cells were at 90% confluency or above to 45% confluency or above, 
discarding extra cells as necessary. Cells were treated at passage 9-10. For tunicamycin 
treatment, cells were split into 6-well plates, 300,000 cells/well, and left for 48 hours. 
After 48 hours, tunicamycin was added to the media to a concentration of 2.5-5ug/mL for 
5 hours or 24 hours, immediately followed by RNA extraction. 
ANIMALS 
Deer mice (Peromyscus maniculatus) were obtained at the time of weaning from 
the Peromyscus Genetic Stock Center (USC), Columbia, SC (RRID:SCR_002769). 
Treatment beyond fibroblast collection was not started until animals were 3 to 4 months 
 63 
old. At that age, animals were placed on a high-fat diet (58% kcal/fat with sucrose, 
Research Diets D12331), with the food being monitored and changed or replenished at 
least weekly or as necessary, for 2 weeks or 6 months. After the specified durations, the 
animals were sacrificed using isoflurane (Thermo-Fisher) as an anesthetic followed by 
cervical dislocation, and the pancreas, liver, kidneys, muscle, and adipose tissue were 
excised, in that exact order, to minimize the breakdown of delicate and sensitive tissues 
as much as possible. Tissues for RNA were immediately frozen using dry ice. Tissues for 
histology were placed in and left in 10% neutral buffered formalin (VWR) for two days 
before replacement with an equal amount of 100% EtOH (Decon). The study was 
approved by the IACUC from the University of South Carolina. 
BLOOD GLUCOSE AND BODY WEIGHT MEASUREMENT 
Following a 6h fast but prior to blood glucose assessment, each animal was placed 
in a container and its weight recorded. Immediately following this, we assessed the blood 
glucose of animals in the six-month treatment group via tail vein puncture using a 30g 
needle (BD). Animals were handled in such a manner that the tail could be held firmly in 
a position which facilitated tail vein puncture and subsequent blood collection. If 
moisture was present on the tail, it was thoroughly dried prior to collection to prevent 
contamination and loss of blood samples due to wicking of the blood droplet. Following 
puncture, any excess blood was removed by paper towel; additionally, if bleeding 
persisted, light pressure was applied to the puncture site until bleeding had stopped. 
Blood glucose was measured using a glucometer once weekly for six months. 
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RNA EXTRACTION, CDNA SYNTHESIS, AND QPCR 
RNA extraction was initially performed using the RNeasy Mini Kit (QIAgen), 
using the supplied protocol, with modifications. Spin time for the wash steps was 
increased from 15s to 30s. The extra spin step prior to elution was included. RNA was 
eluted using 30uL nuclease-free water. This was later changed to All-In-One DNA/RNA 
Miniprep Kit (BioBasic) due to greater RNA yield and quality with the latter kit. In all 
cases, cDNA synthesis was performed using the iScript cDNA synthesis kit (Bio-Rad) 
according to the supplied protocol. qPCR was performed on the T100 thermocycler (Bio-
Rad) using iTaq Universal SYBR Green supermix (Bio-Rad). Oligonucleotide sequences 
used for qPCR amplification were designed using Primer3 and PrimerBLAST and are 
shown in Table 4.01. 
CHOLESTEROL MEASUREMENT 
Following a 6-hour fast, blood for cholesterol measurement was collected from 
animals via submandibular puncture. This was performed once before high-fat diet 
administration, and once immediately prior to sacrifice. Blood samples were captured 
using BD Microtainer tubes, incubated at room temperature for 30-45 minutes, then 
centrifuged at 10,000rpm for 5 minutes to isolate serum. Regardless of circumstances, all 
isolated serum was frozen at -80°C prior to use to ensure that all samples had been treated 
identically. Cholesterol was measured using an HDL and LDL/VLDL Cholesterol Assay 
Kit (Abcam). The procedure was followed as provided with the kit, without modification. 
 
 65 
HISTOLOGY 
At sacrifice, liver was excised from each animal, fixed using 10% neutral buffered 
formalin (VWR) for two days, dehydrated with 100% EtOH, and embedded in wax. 
Paraffin sections were stained with hematoxylin and eosin (H&E). Histological 
examination of the liver specimens was performed blindly for the presence of 
nonalcoholic fatty liver disease (NAFLD) according to the scoring system designed by 
the Pathology Committee of the NASH Clinical Research Network, which addresses the 
full spectrum of lesions of NAFLD (Kleiner et al., 2005). Images shown were obtained 
by a Leica ICC50 HD. 
STATISTICAL ANALYSIS 
Correlations between genes were analyzed by using a two-tailed Student’s t-test, 
Pearson’s correlation, or Spearman’s correlation. All analyses were performed either in 
Microsoft Excel, or using GraphPad Prism 8 software (San Diego, CA). P values are 
shown in the results or Figures and were considered significant if P<0.05. Coordination 
between genes was analyzed by using one-way ANOVA and applying Tukey’s multiple 
comparison test. 
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P. maniculatus BiP, qRT Length Temp GC% Self-Comp (5', 3')
CCAATGACCAGAATCGCCTG For 20 59 55 3, 1 Amplicon Length: 108 Mus Seq Peromyscus Seq Identity Query Co
TCCTGGTATCAATGCGCTCT Rev 20 58.9 50 4, 2 NM_001163434.1 XM_006988727.1 94% 97%
P. maniculatus GRP94, qRT Length Temp GC% Self-Comp (5', 3')
GAGGCCACAGAGAAGGAGTT For 20 59.2 55 4, 0 Amplicon Length: 154 Mus Seq Peromyscus Seq Identity Query Co
TCTCCATGTTGCCAGACCAT Rev 20 59.1 50 4, 3 NM_011631.1 XM_006979864.1 91% 99%
P. maniculatus Calnexin, qRT Length Temp GC% Self-Comp (5', 3')
TTCTGACTGTAGCCTTGCCA For 20 58.9 50 3, 3 Amplicon Length: 118 Mus Seq Peromyscus Seq Identity Query Co
TCCTCCTTCACATCTGGCTG Rev 20 59.1 55 4, 2 NM_001110499.1 XM_006987088.1 90% 96%
P. maniculatus CHOP, qRT Length Temp GC% Self-Comp (5', 3')
TCGCTCTCCAGATTCCAGTC For 20 58.9 55 4, 2 Amplicon Length: 131 Mus Seq Peromyscus Seq Identity Query Co
GTTCCTTCTCCTTCATGCGC Rev 20 59.3 55 4, 4 NM_001290183.1 XM_006973295.1 88% 61%
P. maniculatus LDLR, qRT Length Temp GC% Self-Comp (5', 3')
GGCCCAACAAGTTCAAGTGT For 20 58 50 4, 3 Amplicon Length: 138 Mus Seq Peromyscus Seq Identity Query Co
CACCATTGTTGTCCAAGCAC Rev 20 58 50 5, 2 NM_001252658.1 XM_006982333.2 88% 78%
P. maniculatus LIPC/HL, qRT Length Temp GC% Self-Comp (5', 3')
GACTCCTTGCGACACAGTGA For 20 58 55 5, 3 Amplicon Length: 125 Mus Seq Peromyscus Seq Identity Query Co
CGGATGTCATAGCCCAGAGT Rev 20 58 55 5, 1 NM_001324472.1 XM_015997939.1 89% 89%
P. maniculatus LPL, qRT Length Temp GC% Self-Comp (5', 3')
GCCACCTCATTCCTGGAGTA For 20 59 55 5, 3 Amplicon Length: 118 Mus Seq Peromyscus Seq Identity Query Co
GGCACCCAACTCTCGTACAT Rev 20 59 55 4, 2 NM_008509.2 XM_006989568.2 87% 88%
P. maniculatus LAMP1, qRT Length Temp GC% Self-Comp (5', 3')
ACTGGTGAAAACGGAACCTG For 20 58 50% 3, 1 Amplicon Length: 125 Mus Seq Peromyscus Seq Identity Query Co
CCATGAGCTGTGTCATTTGG Rev 20 57 50% 4, 0 NM_001317353.1 XM_015999785.1 85% 87%
P. maniculatus ATG5, qRT Length Temp GC% Self-Comp (5', 3')
TGCCGTCCTTAAACCTCAAC For 20 58 50 4, 0 Amplicon Length: 82 Mus Seq Peromyscus Seq Identity Query Co
AGGGCTTCAGCTGCATGTAT Rev 20 59 50 6, 2 XM_011243108.2 XM_006996705.2 92% 83%
P. maniculatus ATG14, qRT Length Temp GC% Self-Comp (5', 3')
ACTCGTGCGGTGAAGAGACT For 20 61 55 3, 3 Amplicon Length: 96 Mus Seq Peromyscus Seq Identity Query Co
CCTGAGGGTATGCAGTGGTT Rev 20 59 55 5, 1 NM_172599.4 XM_016006027.1 92% 48%
P. maniculatus GAPDH, qRT Length Temp GC% Self-Comp (5', 3')
GTCGGAGTGAACGGATTTGG For 20 58.9 55 3, 0 Amplicon Length: 141 Mus Seq Peromyscus Seq Identity Query Co
GGTGGAGTCGTACTGGAACA Rev 20 59 55 4, 1 NM_001289726.1 XM_006992087.1 90% 92%
Rattus norvegicus BiP, qRT Length Temp GC% Self-Comp (5', 3')
TGCAGCAGGACATCAAGTTC For 20 60 50 5, 3 Amplicon Length: mRNA SEQUENCE USED
TTTCTTCTGGGGCAAATGTC Rev 20 60 45 3, 2 111 NM_013083.2
Rattus norvegicus GRP94, qRT Length Temp GC% Self-Comp (5', 3')
TGATGATGAAGCCGCAGTAG For 20 60 50 3, 0 Amplicon Length: mRNA SEQUENCE USED
AAGTTCCCAGTCCCACACAG Rev 20 60 55 3, 1 88 NM_001012197.2
Rattus norvegicus Calnexin, qRT Length Temp GC% Self-Comp (5', 3')
CCTCAGATTGCCAACCCTAA For 20 60 50 5, 3 Amplicon Length: mRNA SEQUENCE USED
AGGCTTCCATTTGCCCTTAT Rev 20 60 45 3, 2 99 NM_172008.2
Rattus norvegicus CHOP, qRT Length Temp GC% Self-Comp (5', 3')
CATGAACTGTTGGCATCACC For 20 60 50 5, 1 Amplicon Length: mRNA SEQUENCE USED
TCTACCCTCAGTCCCCTCCT Rev 20 60 60 3, 0 116 NM_001109986.1 (Var. 1)
(bp 151-813)
Rattus norvegicus HL, qRT Length Temp GC% Self-Comp (5', 3')
TTGACTCCTTGCAACACAGC For 20 60 50 6, 2 Amplicon Length: mRNA SEQUENCE USED
GCCCTTCTTGCAGTTCAGAC Rev 20 60 55 4, 1 98 NM_012597.2
Rattus norvegicus GAPDH, qRT Length Temp GC% Self-Comp (5', 3')
TGCCACTCAGAAGACTGTGG For 20 60 55 4, 0 Amplicon Length: mRNA SEQUENCE USED
GGATGCAGGGATGATGTTCT Rev 20 60 50 4, 0 85 NM_017008.4
Peromyscus qPCR Primers
Rat qPCR Primers
mRNA SEQUENCES USED BLAST DATA
mRNA SEQUENCES USED BLAST DATA
mRNA SEQUENCES USED BLAST DATA
mRNA SEQUENCES USED BLAST DATA
mRNA SEQUENCES USED BLAST DATA
mRNA SEQUENCES USED BLAST DATA
mRNA SEQUENCES USED BLAST DATA
mRNA SEQUENCES USED BLAST DATA
mRNA SEQUENCES USED BLAST DATA
mRNA SEQUENCES USED BLAST DATA
mRNA SEQUENCES USED BLAST DATA
  
Table 4.01: List of primers used for qPCR analysis. 
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